98 related articles for article (PubMed ID: 23881290)
1. Potential interactions with anticancer agents: a cross-sectional study.
Mouzon A; Kerger J; D'Hondt L; Spinewine A
Chemotherapy; 2013; 59(2):85-92. PubMed ID: 23881290
[TBL] [Abstract][Full Text] [Related]
2. Potential drug interactions and duplicate prescriptions among cancer patients.
Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
[TBL] [Abstract][Full Text] [Related]
3. A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital.
Kannan G; Anitha R; Rani VN; Thennarasu P; Alosh J; Vasantha J; Martin JR; Uma MR
J Postgrad Med; 2011; 57(3):206-10. PubMed ID: 21941058
[TBL] [Abstract][Full Text] [Related]
4. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
Lemachatti J; Levêque D; Beretz L; Bergerat JP
Anticancer Res; 2009 Nov; 29(11):4741-4. PubMed ID: 20032429
[TBL] [Abstract][Full Text] [Related]
5. [Drug interactions with anticancer agents].
Furue H
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2231-6. PubMed ID: 3907502
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.
Voll ML; Yap KD; Terpstra WE; Crul M
Pharm World Sci; 2010 Oct; 32(5):575-80. PubMed ID: 20645002
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study.
Hadjibabaie M; Badri S; Ataei S; Moslehi AH; Karimzadeh I; Ghavamzadeh A
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1619-27. PubMed ID: 23589317
[TBL] [Abstract][Full Text] [Related]
8. Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.
Santucci R; Levêque D; Lescoute A; Kemmel V; Herbrecht R
Anticancer Res; 2010 Sep; 30(9):3807-10. PubMed ID: 20944174
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the drug interactions associated to domiciliary drug therapy in elderly hospitalized patients].
Iniesta-Navalón C; Urbieta-Sanz E; Gascón-Cánovas JJ
Rev Clin Esp; 2011; 211(7):344-51. PubMed ID: 21640341
[TBL] [Abstract][Full Text] [Related]
10. Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
Santucci R; Levêque D; Kemmel V; Lutz P; Gérout AC; N'guyen A; Lescoute A; Schneider F; Bergerat JP; Herbrecht R
Anticancer Res; 2010 Mar; 30(3):963-5. PubMed ID: 20393020
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
12. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center.
Chan A; Leow YC; Sim MH
J Oncol Pharm Pract; 2009 Sep; 15(3):161-5. PubMed ID: 19171555
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions with oral antineoplastic drugs: The role of the pharmacist.
Riu-Viladoms G; Carcelero San Martín E; Martín-Conde MT; Creus N
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12944. PubMed ID: 30324634
[TBL] [Abstract][Full Text] [Related]
14. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital.
Yusuff KB; Balogun OB
Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):69-74. PubMed ID: 15508134
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes.
Song X; Varker H; Eichelbaum M; Stopfer P; Shahidi M; Wilson K; Kaiser R; Finnern HW
Lung Cancer; 2011 Oct; 74(1):103-11. PubMed ID: 21382644
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions between chemotherapeutic regimens and antiepileptics.
Yap KY; Chui WK; Chan A
Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
[TBL] [Abstract][Full Text] [Related]
20. Prescribing pattern of acid suppressive medications for medical inpatients in a teaching hospital in Qatar.
Khudair IF; Sadik ND; Hanssens YI
Saudi Med J; 2009 Jan; 30(1):125-9. PubMed ID: 19139786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
